| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 119,958 | 132,874 | 148,649 | | Cost of Revenue | 52,480 | 33,151 | 34,389 | | | Gross Profit | 67,478 | 99,723 | 114,260 | | | Operating Expenses | | Research Development | 39,250 | 44,511 | 44,513 | | Selling General and Administrative | 59,970 | 63,496 | 53,791 | | Non Recurring | 60,121 | 3,152 | 4,416 | | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (91,863) | (11,436) | 11,540 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (333) | 3,124 | 2,805 | | Earnings Before Interest And Taxes | (92,196) | (8,312) | 14,345 | | Interest Expense | 767 | 1,479 | 2,024 | | Income Before Tax | (92,963) | (9,791) | 12,321 | | Income Tax Expense | 25,160 | (4,254) | 6,071 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (118,123) | (5,537) | 6,250 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (118,123) | (5,537) | 6,250 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($118,123) | ($5,537) | $6,250 |
|
1.48% Nasdaq 
Income Statement
